Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 40 and 80 years of age
- People who have been diagnosed with hip and/or knee osteoarthritis according to specific rheumatology guidelines set by the American College of Rheumatology
- People experiencing a moderate to severe level of pain that interferes with daily life, as measured by a specific pain questionnaire (confirm with trial site for exact score details)
- People who have not started any new pain medications or osteoarthritis treatments in the past 4 weeks
- People who are able to read, understand, and self-report in English or French
Who may not be able to join:
- People who have hip or knee surgery planned within the next 4 months
- People who have had an injection into the affected joint(s) — such as cortisone or platelet-rich plasma — within the past 3 months
- People who have a joint injection planned during the trial period
- People who have an inflammatory type of arthritis, such as rheumatoid arthritis, psoriatic arthritis, or gout
- People who have medical reasons why they should not take cannabis or cannabinoid-based products
- People who have used the cannabinoid medications nabilone or nabiximols in the past 30 days
- People who have used cannabis — whether medical or recreational — in the past 30 days
- People who have a history of a diagnosed cannabis use disorder or dependence
- People who currently have an active substance use disorder
- People who currently have a diagnosis of bipolar disorder, major depression, or psychosis as defined by standard psychiatric guidelines
- People who have an uncontrolled medical condition or major psychiatric disorder
- People who are currently taking the blood-thinning medication warfarin
- People who are known to be pregnant or who are currently breastfeeding
- People — both men and women — who are planning a pregnancy during the study or within 12 weeks after the study medications are stopped
- People who do not have a fixed address, or who plan to change address within the next 4 months
- People who have a known or suspected allergy to palm oil or coconut oil
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr. Hance Clarke, MD, University Health Network, Toronto
Phone: 1-416-340-4800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility outcome: pertaining to the enrollment rate; Feasibility outcome: pertaining to the Protocol adherence; Feasibility outcome: pertaining to data completeness
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.